论文部分内容阅读
目的:在对胰腺炎患者采用奥曲肽进行治疗时采取不同的应用方式,并对其临床的治疗效果进行观察并分析。方法:选取自2013年1月至2014年7月间在我院进行治疗的胰腺炎患者共计164例,根据患者选择的奥曲肽的应用方法将其分为对照组与观察组,每组各82例患者,对照组患者采取皮下注射的方式应用奥曲肽对患者进行治疗,观察组患者则采取微量注射泵持续注射给药的治疗方法,由护理人员对患者临床的治疗效果进行观察与对比,不良反应的发生情况以及临床症状指标的变化进行观察与对比。结果:经过治疗,观察转折临床治疗的总有效率为90%,对照组患者为80%,比较的差异有着统计学意义(P<0.05);观察组患者在血淀粉酶的恢复时间,临床体征的消失时间,进食的恢复时间以及住院时间方面均要明显短于对照组患者(P<0.05);观察组患者不良反应的发生率为10%,复发率为5%,对照组患者则分别达到了20%与10%,其比较差异具有着显著性(P<0.05)。结论:在对胰腺炎患者采用奥曲肽进行治疗时,应选择微量注射泵持续注射给药的治疗方法,其具有着更为理想的临床应用效果,值得应用并推广。
Objective: In the treatment of patients with pancreatitis using octreotide take a different application, and its clinical treatment was observed and analyzed. Methods: A total of 164 patients with pancreatitis treated in our hospital from January 2013 to July 2014 were selected and divided into control group and observation group according to the application of octreotide selected by patients Patients and control patients were treated with octreotide subcutaneously on the patients. The patients in the observation group were treated by continuous injection with a microinjection pump. The clinical effects of the patients were observed and compared by nurses. Adverse reactions The occurrence of clinical symptoms and indicators of changes were observed and compared. Results: After treatment, the total effective rate of clinical treatment of turning point was 90% and that of the control group was 80%, the difference was statistically significant (P <0.05); the recovery time of blood amylase, clinical signs (P <0.05). In the observation group, the incidence of adverse reactions was 10%, the recurrence rate was 5%, and the control group patients were reached respectively 20% and 10%, the difference was significant (P <0.05). Conclusion: In patients with pancreatitis using octreotide for treatment, should choose microinjection pump continuous injection therapy, which has a more ideal clinical application, it is worth to apply and promote.